Excerpts

Gum bleeding was more common in employed individuals (17.3%, p = 0.015) and showed a trend by financial status ( p = 0.009), with the highest prevalence among those with “bad” status (19.7%).

Furthermore, a highly significant surface elevation of CD4 (p = 0.009) and CD45RA (p = 0.001) was observed ( Figure 1A ).

Almost significant improvements were observed in the ExG in upper limb flexibility, namely in the one with worst scores at start (MD [95% CI]: ExG – 3.6 cm [0.9; 6.4], p = 0.009).

Future perspectives were significantly different between PAC and CG post-intervention (MD [95% CI]: 23.7 [6.2; 41.3], p = 0.004, scale range 0–100) and borderline significant between ExG and CG (MD [95% CI]: 21.8 [4.2; 39.3], p = 0.009, scale range 0–100).

The lipid profiles varied among the three groups, although these differences failed to reach significance, with the exception of LDL-cholesterol, which was significantly higher in the unstable angina patients than in the control subjects ( p = 0.009).

Nonetheless, two pathways were nominally significant (eTable 6): drug metabolism ( p = 0.009) and pyrimidine nucleoside catabolic processes ( p = 0.04).

TMTV ≥ 135 cm 3 was highly significant at univariate analysis ( P = 0.009).

The results showed that good body conditioned cows suffered less (35.90%), whereas poor body condition cows suffered more (64.4%) with SCM and these differences were highly significant (P = 0.009).

Box's conservative epsilon), the differences in QN IC 50 were highly significant (p < 0.009) at concentrations relevant with AVA plasma concentrations achievable in patients taking 80 mg of AVA daily (Table 1 ).

Treatment of animals with Rac1 peptide at all doses failed to influence clinical scores of disease severity or animal weight (data not shown), but animals treated with 2 mg of Rac1 peptide showed a highly significant decrease in paw swelling when compared with treatment with Ctrl peptide (61% reduction, P = 0.009) (Figure 2a, b ).

Amino acid (collagen) concentration was surprisingly variable within a single bone, yet when amino acid content was compared with DNA amplification there was a significant difference between successful and failed samples ( p = 0.016), and this difference becomes highly significant ( p = 0.009) if the test compares ‘good’ and ‘failed’ amplifications.

Among NHB participants, the interaction remained significant for episodic memory ( β = −0.092, 95% CI = [−0.142, −0.041], p < 0.001, p _FDR = 0.005) and marginally significant for executive function ( β = −0.073, 95% CI = [−0.129, −0.018], p = 0.009, p _FDR = 0.056).

A significant trend towards increased risk was observed in the potentially less protective genotype GSTM1 / CYP1A1 ( p < 0.009, (Χ 2 trend test).

No significant difference was found for >1.8 s between blue- and red-light stimulus ( t (14) = -1.2, p = 0.125, d = -0.31), but highly significant difference in pupillary change to blue- compared to red-light for <1.7 s ( t (14) = -2.71, p = 0.009, d = -0.70), see Fig 4 .

45% [95% CI, 34–59] in non‐CR patients, p = .051) and a highly significant improvement of 5‐year OS ( p = .009), but not of lung‐RFS ( p = .3).

The correlation between the residualized change scores of psychological flexibility and quality of life in the environment dimension failed to reach significance in the pre-treatment to post-treatment comparison ( p = .009) but was significant in the pre-treatment to follow-up-comparison.

This endpoint treatment effect was then sustained over time: in follow up intention‐to‐treat (ITT) analysis 6 years after initial treatment end, with 80% of the original cohort assessed at a mean age 10.5 years, the between‐group treatment effect on ADOS scores was preserved (OR −8.2; −1.53, −0.12, p = 0.02), giving a highly significant cumulative effect of therapy (marginal log‐odds effect size of 0.55 [95% CI 0.14–0.91]; p = 0.009; shown as an ‘area between curves’ AUC, Figure 3 ).

For the 6% B 4 C composite, feed rate remains highly significant (F = 15.72, p = 0.009), contributing over 46% to surface roughness variation.

In this independent data, we observed a highly significant predictive performance ( r = 0.34 CI 90% : [0.14 0.53], p = 0.009, Fig. 1c – External model performance).

3.02 ng/ml, nearly significant p = .009) and formula-feeding arms (3.21 vs. 1.50 ng/ml (p = .002) and also for D-dimer in the breastfeeding (1.40 vs. 0.40 ng/ml (p<.001) and formula-feeding arms (1.32 vs. 0.52 ng/ml, p<.001) ( Table 2 ).

By removing probe 3 (detected as BAD: quality score = 2.5e-5, additional file 2 ), the P-value becomes highly significant (p = 0.009).

The overall B/N ratio showed an increasing trend over time ( p = 0.009), and the increase was also most evident in children aged <5 years ( p = 0.020) ( Figure 1B ).

Most GMP positive tumors (9 of 14 cases) had HER2-enriched or basal-like phenotypes, and the association with the basal-like group was highly significant when compared with the other subgroups (OR 5.4, P = 0.009).

Approximately half the comparisons based on locus Lpol03 yielded highly significant F ST values after Benjamini–Yekutieli correction (ranging from 0.0772 to 0.2543, P < 0.00908).

Overall, a third (7/21) of the individuals with some type of amino acid mutation were asymptomatic, while the other two-thirds presented some symptom or disease associated with the presence of HTLV-1, a highly significant difference ( p = 0.0091).